CINECA IRIS Institutional Research Information System

BARRESI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.988
AS - Asia 3.529
EU - Europa 3.429
SA - Sud America 521
AF - Africa 235
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.712
IT - Italia 1.524
SG - Singapore 1.198
CN - Cina 1.022
HK - Hong Kong 519
BR - Brasile 417
DE - Germania 398
SE - Svezia 365
CA - Canada 194
AT - Austria 193
BG - Bulgaria 179
VN - Vietnam 176
GB - Regno Unito 166
IN - India 127
RU - Federazione Russa 127
FR - Francia 122
FI - Finlandia 105
JP - Giappone 100
KR - Corea 72
TR - Turchia 65
CI - Costa d'Avorio 53
MX - Messico 45
NL - Olanda 43
NG - Nigeria 41
PL - Polonia 41
BD - Bangladesh 40
SN - Senegal 38
IQ - Iraq 37
UA - Ucraina 36
AR - Argentina 35
ZA - Sudafrica 32
AU - Australia 31
BE - Belgio 31
PK - Pakistan 28
UZ - Uzbekistan 24
ES - Italia 22
EG - Egitto 21
SA - Arabia Saudita 21
CZ - Repubblica Ceca 15
EC - Ecuador 15
KE - Kenya 15
VE - Venezuela 15
JO - Giordania 12
MA - Marocco 12
ID - Indonesia 11
LT - Lituania 11
AZ - Azerbaigian 10
CO - Colombia 10
CH - Svizzera 9
PY - Paraguay 9
JM - Giamaica 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
OM - Oman 7
IE - Irlanda 6
KZ - Kazakistan 6
PE - Perù 6
CL - Cile 5
LB - Libano 5
MY - Malesia 5
RO - Romania 5
AL - Albania 4
EE - Estonia 4
HU - Ungheria 4
IL - Israele 4
PH - Filippine 4
TW - Taiwan 4
UY - Uruguay 4
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
IR - Iran 3
PA - Panama 3
BB - Barbados 2
GR - Grecia 2
GY - Guiana 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SO - Somalia 2
ZM - Zambia 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
Totale 13.709
Salva come PNG Salva come JPEG
Città #
Ashburn 720
Singapore 628
Serra 561
Hong Kong 509
Dallas 473
Santa Clara 398
Woodbridge 393
Fairfield 363
Ann Arbor 343
Chandler 332
Houston 310
Shanghai 222
Beijing 196
New York 187
Sofia 179
Seattle 171
Vienna 165
Los Angeles 149
Ottawa 149
Wilmington 132
Boardman 121
Frankfurt am Main 116
Hefei 110
Princeton 109
Cambridge 105
Pisa 102
Milan 89
Munich 83
Lawrence 78
Medford 73
Des Moines 70
Seoul 67
Abidjan 53
Council Bluffs 51
Florence 51
Redondo Beach 49
Dearborn 47
London 47
Turku 47
São Paulo 43
Tokyo 43
Rho 41
Bremen 40
Lagos 39
Dakar 38
Ho Chi Minh City 38
San Jose 37
Istanbul 35
Buffalo 34
Warsaw 34
Nanjing 31
Rome 31
Brussels 30
Lucca 29
Livorno 28
Dong Ket 25
Helsinki 23
Tashkent 23
Hanoi 22
Sydney 22
Boulder 20
Pune 20
Pessac 19
Nuremberg 18
Ogden 18
San Diego 18
Toronto 18
Johannesburg 17
Montreal 17
Paris 17
Cascina 16
Jacksonville 16
Manchester 16
Changsha 15
Chicago 15
Denver 15
Düsseldorf 15
Fort Wayne 15
Fuzhou 15
Guangzhou 15
Izmir 15
Pistoia 15
Amsterdam 14
Stockholm 14
Aversa 13
Chennai 13
Quanzhou 13
Redwood City 13
Shenyang 13
The Dalles 13
Vicopisano 13
Alessandria 12
Amman 12
Dhaka 12
Baghdad 11
Kunming 11
Mexico City 11
Phoenix 11
San Giuliano Terme 11
Vercelli 11
Totale 9.320
Salva come PNG Salva come JPEG
Nome #
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 319
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 266
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 260
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 248
Allosteric modulators of human A2B adenosine receptor. 221
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 219
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 214
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 212
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 211
An update into the medicinal chemistry of translocator protein (TSPO) ligands 201
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 198
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 198
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 197
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 190
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 185
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 183
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 182
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 174
Metformin conjugates and therapeutic use thereof 173
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 173
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 172
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 169
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 169
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 163
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 163
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 162
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 160
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 157
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 156
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 153
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 153
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 153
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 151
Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor 150
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 148
Carbonic anhydrase activation profile of indole-based derivatives 148
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 145
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 143
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 143
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 142
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 141
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas 141
Structure-Activity Relationship Refinement and Further Assessment of 4-Phenylquinazoline-2-carboxamide Translocator Protein Ligands as Antiproliferative Agents in Human Glioblastoma Tumors. 137
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 135
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 135
De novo neurosteroidogenesis in human microglia: Involvement of the 18 kda translocator protein 135
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 134
Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications 132
Allosteric modulation of A2B adenosine receptors potentiate the effects of orthosteric receptor agonists to promote mesenchymal stem cell differentiation to osteoblasts. 131
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 131
Allosteric Modulators of Adenosine Receptors 130
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 130
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 130
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 128
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 128
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 127
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 125
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 124
Glioblastoma multiforme: induction of mitochondria-mediated apoptotic pathway by simultaneous pharmacological activation of TSPO (18KDa) and p53. 117
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 116
Interaction of the irreversible ligand IRDE-MPIGA with TSPO (18 KDa): new insight on TSPO role in tumor cells. 115
Development of a New A2B Adenosine Receptors PET ligand: 3- Phenyl-1-[11C]methyl-3- aryl[1,2,4]triazino[4,3 -a]benzimidazol-4(10H)-one 115
Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties 115
Design and synthesis of novel indolylglyoxylamide derivatives as molecular probes for 18 KDa translocator protein (TSPO) 113
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview 112
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 112
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 111
Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging 110
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 109
18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile 108
Translocator Protein 18-kDa: a promising target to treat neuroinflammation-related degenerative diseases 108
Strategies for the improvement of metal-based chemotherapeutic treatments 105
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry 105
Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities 104
TSPO Radioligands for Neuroinflammation: An Overview 104
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 103
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 98
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents 96
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies 95
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 94
Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer 92
From conventional therapy to novel nano-based approaches. A focus on prostate cancer 92
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 92
Enhancing the Anticancer Activity of Attenuated Listeria monocytogenes by Cell Wall Functionalization with “Clickable” Doxorubicin 91
Development of novel indole-based tdp1 inhibitors for anticancer therapy 89
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 89
Lead optimization of a novel molecular scaffold in search for novel MMP-13 inhibitors 87
Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies 86
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 86
Radiosynthesis of the TSPO 18 kDa PET Radiotracer [18F](R)-PK14105 83
Enriching the arsenal of pharmacological tools against mical2 83
Indole-based modulators of p53/MDM2 interaction as antitumoral agents 82
H2S-releasing properties of new thioamide derivatives 82
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides. 80
2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting 78
Modulation of PAR1 signaling by benzimidazole compounds 78
Labeling of TSPO PET radioligands by [18F]fluorination of diarylsulfoxide precursors 73
Carbonic Anhydrase Activators for Neurodegeneration: An Overview 71
N,N-dialkyl-5-isothiocyanato-2-phenylindol-3-ylglyoxylamide: an irreversible ligand to study the translocator protein 71
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview 70
Totale 13.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021401 0 0 0 0 0 24 14 61 90 63 50 99
2021/20221.037 41 91 53 39 137 166 55 46 34 34 45 296
2022/20231.532 162 207 127 146 151 190 14 97 324 13 71 30
2023/20241.123 59 72 104 40 119 249 129 44 11 30 131 135
2024/20253.956 31 111 56 203 347 414 273 141 365 451 447 1.117
2025/20262.771 258 587 562 466 550 348 0 0 0 0 0 0
Totale 14.103